Malone, Brandon
Simovski, Boris
Moliné, Clément
Cheng, Jun
Gheorghe, Marius
Fontenelle, Hugues
Vardaxis, Ioannis
Tennøe, Simen
Malmberg, Jenny-Ann
Stratford, Richard
Clancy, Trevor
Article History
Received: 21 June 2020
Accepted: 30 November 2020
First Online: 23 December 2020
Competing interests
: BS, CM, MG, HF, IV, ST, JM, RS and TC are employees of NEC OncoImmunity, a subsidiary of NEC Corporation. BM and JC are employees of NEC Laboratories Europe. The authors declare no competing interests.